Lucy Scientific Discovery Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021
Cash & Equivalents	1.67	0.05	0.25
Short-Term Investments	0	0.03	0
Cash & Cash Equivalents	1.67	0.09	0.25
Cash Growth	1813.33%	-64.44%	-
Receivables	0.34	0	0
Other Current Assets	1.8	1.81	1.76
Total Current Assets	3.82	1.9	2.01
Property, Plant & Equipment	0	0.84	0.84
Long-Term Investments	0	0.02	0.02
Goodwill and Intangibles	1.48	0	0
Other Long-Term Assets	3.47	1.87	2.68
Total Long-Term Assets	4.96	2.73	3.55
Total Assets	8.78	4.63	5.55
Accounts Payable	2.31	4.59	3.53
Deferred Revenue	0	1.61	1.68
Current Debt	0.06	1.22	1.25
Other Current Liabilities	0.34	-1.61	-1.68
Total Current Liabilities	2.71	5.81	4.77
Long-Term Debt	0	3.6	0.94
Other Long-Term Liabilities	1.39	0	6.19
Total Long-Term Liabilities	1.39	3.6	7.14
Total Liabilities	4.1	9.41	11.91
Total Debt	0.06	4.82	2.19
Debt Growth	-98.75%	119.95%	-
Retained Earnings	-44.42	-35.43	-29.57
Comprehensive Income	0.16	-0.14	-0.35
Shareholders' Equity	4.68	-4.78	-6.36
Net Cash / Debt	1.61	-4.73	-1.95
Net Cash Per Share	1.27	-5.49	-3.63
Working Capital	1.11	-3.91	-2.77
Book Value Per Share	3.68	-5.55	-11.85

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).